| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 11,110 | $47.65 | $529,403.72 | -4.8% | |
| Jul 28, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $47.99 | $379,090.19 | -100% | |
| Jul 15, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $49.53 | $619,118.25 | -24.2% | |
| Jul 14, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $48.85 | $385,876.29 | -100% | |
| Jul 13, 2020 | Horn Howard81 | CFO | Sell | 30,000 | $50.06 | $1,501,731.00 | -14.4% | |
| Jul 2, 2020 | Horn Howard81 | CFO | Sell | 20,000 | $38.92 | $778,398.75 | -2.3% | |
| Jul 1, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $37.78 | $472,252.00 | -24.2% | |
| Jul 1, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 75,000 | $37.95 | $2,846,310.00 | -25.2% | |
| Jun 25, 2020 | Horn Howard81 | CFO | Sell | 30,000 | $50.00 | $1,500,000.00 | -11.6% | |
| Jun 24, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 14,920 | $44.64 | $666,057.73 | -100% |